Market Overview

Dicerna Pharmaceuticals (NASDAQ: DRNA)

19.15 -0.54 (-2.74%)

Earnings

QuarterPriorEstimateActualSurprise
Q2 2021
Pre-Market
EPS:
REV:




Q1 2021
After-Hours
EPS:
REV:
-0.31
34.028M



Q4 2020
After-Hours
EPS:
REV:
-0.58
7.08M



Q3 2020
After-Hours
EPS:
REV:
-0.45
8.035M



Q2 2020
Pre-Market
EPS:
REV:
-0.35
5.682M
0.1
62.3M
-0.43
40.448M
-530%
-35.08%
Q1 2020
After-Hours
EPS:
REV:
-0.38
3.107M
0.27
59.83M
-0.31
34.028M
-214.81%
-43.13%
Q4 2019
After-Hours
EPS:
REV:
-0.29
1.541M
0.55
84.75M
-0.58
7.08M
-205.45%
-91.65%
Q3 2019
After-Hours
EPS:
REV:
-0.35
1.545M
-0.28
11.06M
-0.45
8.035M
-60.71%
-27.35%
Q2 2019
After-Hours
EPS:
REV:
-0.68
1.545M
-0.31
10.29M
-0.35
5.682M
-12.9%
-44.78%
Q1 2019
After-Hours
EPS:
REV:
-0.30
1.545M
-0.22
10.3M
-0.38
3.107M
-72.73%
-69.83%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!